CA2259997A1 - Remedies and preventives for stomatitis - Google Patents

Remedies and preventives for stomatitis

Info

Publication number
CA2259997A1
CA2259997A1 CA002259997A CA2259997A CA2259997A1 CA 2259997 A1 CA2259997 A1 CA 2259997A1 CA 002259997 A CA002259997 A CA 002259997A CA 2259997 A CA2259997 A CA 2259997A CA 2259997 A1 CA2259997 A1 CA 2259997A1
Authority
CA
Canada
Prior art keywords
stomatitis
preventives
remedies
zinc
carnosinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002259997A
Other languages
French (fr)
Other versions
CA2259997C (en
Inventor
Masaaki Hirano
Shirou Katayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamari Chemicals Ltd
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co., Ltd.
Hamari Chemicals Co., Ltd.
Masaaki Hirano
Shirou Katayama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP19164096A external-priority patent/JP3877807B2/en
Application filed by Zeria Pharmaceutical Co., Ltd., Hamari Chemicals Co., Ltd., Masaaki Hirano, Shirou Katayama filed Critical Zeria Pharmaceutical Co., Ltd.
Publication of CA2259997A1 publication Critical patent/CA2259997A1/en
Application granted granted Critical
Publication of CA2259997C publication Critical patent/CA2259997C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preventives/remedies for stomatitis containing L-zinc carnosinate salt or L-carnosin/zinc complex optionally together with sodium alginate. These drugs are excellent in the effects of treating and preventing stomatitis, in particular, one caused by chemotherapy or radiation therapy for cancer.
CA002259997A 1996-07-03 1997-06-25 Remedies and preventives for stomatitis Expired - Fee Related CA2259997C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8/191640 1996-07-03
JP19164096A JP3877807B2 (en) 1996-07-03 1996-07-03 Stomatitis treatment / prevention agent
PCT/JP1997/002192 WO1998001146A1 (en) 1996-07-03 1997-06-25 Preventives/remedies for stomatitis

Publications (2)

Publication Number Publication Date
CA2259997A1 true CA2259997A1 (en) 1998-01-15
CA2259997C CA2259997C (en) 2006-02-21

Family

ID=35985387

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259997A Expired - Fee Related CA2259997C (en) 1996-07-03 1997-06-25 Remedies and preventives for stomatitis

Country Status (1)

Country Link
CA (1) CA2259997C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016210409A1 (en) * 2015-06-26 2016-12-29 Di Rocco Richard J L-carnosine zinc formulations and methods of use

Also Published As

Publication number Publication date
CA2259997C (en) 2006-02-21

Similar Documents

Publication Publication Date Title
HU9302384D0 (en) 2,4-diamino-quinazoline derivatives and medical preparatives containing them
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
AU5835098A (en) Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
CA2083179A1 (en) Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
ZA973105B (en) Compounds and methods for the selective treatment of cancer and bacterial infections.
EP0659209A4 (en) Cancer therapy utilizing malignant cells.
CA2117891A1 (en) Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
AU9312198A (en) Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
CA2214131A1 (en) Trisubstituted phenyl derivatives
AU581853B2 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
AU3274597A (en) Remedies and preventives for stomatitis
GB9521608D0 (en) Pharmaceutical composition
AU1480497A (en) Cancer treatment
AU1214892A (en) Amide-chelates, their metal complexes as well as their use in diagnosis and treatment
CA2298820A1 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
CA2259997A1 (en) Remedies and preventives for stomatitis
MD798G2 (en) Method of the mamma cancer treatment
AU1214792A (en) Chelates, their metal complexes as well as their use in diagnosis and treatment
CA2283450A1 (en) Methods for treatment of scar tissue
WO2000040752A3 (en) Cancer associated genes and their products
AU1067595A (en) Aryl halide substituted metallic complexes, pharmaceuticals containing these complexes, their use for diagnostic purposes, and methods for preparing the complexes and pharmaceuticals
AU559768B2 (en) Aluminium or zinc panthenolate and their use for treating wounds
AU3255295A (en) Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions
CA2172607A1 (en) Phorbine Derivatives and Their Use in the Diagnosis and Therapy of Cancer
AU3582995A (en) Combination immunotoxin/antineoplastic agent therapy for b-lineage cancer

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160627